Securities Registration (section 12(g)) (8-a12g)

Date : 09/05/2019 @ 7:37PM
Source : Edgar (US Regulatory)
Stock : Pharmagreen Biotech Inc. (PHBI)
Quote : 0.405  -0.02 (-4.71%) @ 8:59PM

Securities Registration (section 12(g)) (8-a12g)

   

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-A


FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) or 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

PHARMAGREEN BIOTECH Inc.

(Exact name of Registrant as specified in its charter)


 

Nevada

26-1679929

(State of Incorporation)

(I.R.S. Employer
Identification No.)

 

 

2987 Blackbear Court,

Coquitlam, British Columbia


V4E 3A2

(Address of principal executive offices)

(Zip Code)

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

Title of each class

to be so registered

Name of each exchange of which

each class is to be registered

 

 

Not applicable

Not applicable

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A(c), check the following box. o

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A(d), check the following box. x

 

Securities Act registration statement file number to which this form relates: No. 333-230413

Securities to be registered pursuant to Section 12(g) of the Act:

 

COMMON STOCK, PAR VALUE $0.001 PER SHARE 

(Title of Class)

 

 




 

 




Item 1. Description of Registrant’s Securities to be Registered.

 

The description of the Common Stock of the Registrant is set forth under the caption “Description of Securities” in the Registrant’s Registration Statement on Form S-1 (File No. 333-230413) as filed with the Securities and Exchange Commission on March 20, 2019, and including any form of prospectus therein filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which description is herein incorporated by reference. 

 

Item 2. Exhibits

 

Exhibit No.

Description

3.1

Articles of Incorporation*

3.2

Bylaws*


* As filed in the Registrant’s Registration Statement on Form S-1 (File No. 333-230413) on March 20, 2019.


SIGNATURES

 

In accordance with Section 12 of the Exchange Act of 1934, the Registrant duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Pharmagreen Biotech Inc.

(Registrant)



Date: September 5, 2019

By: /s/ Peter Wojcik  

Peter Wojcik

President and Director

Principal Executive Officer


/s/ Terry Kwan

Terry Kwan

Principal Accounting Officer


 

 



2



Pharmagreen Biotech Inc. (USOTC:PHBI)
Historical Stock Chart

1 Year : From Jan 2019 to Jan 2020

Click Here for more Pharmagreen Biotech Inc. Charts.

Pharmagreen Biotech Inc. (USOTC:PHBI)
Intraday Stock Chart

Today : Monday 27 January 2020

Click Here for more Pharmagreen Biotech Inc. Charts.

Latest PHBI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.